Table 2.
Drug product release testing and specifications.
| Product attribute | Test | Specification |
|---|---|---|
| Identity | Vector copy number (VCN) | 0.01–5.0 copies per cell |
| Identity | Total number of transduced cells | 0.1–5.0 x 109 cells |
| Identity | VCN per transduced cell | < 5 VCN/transduced cell |
| Identity | Frequency of Gag-specific CD4 T cells | Report results |
| Identity | Frequency of CD3 and CD4 cells | CD3: ≥80%; CD4: ≥50% |
| Purity | Cell viability | ≥70% |
| Microbial safety | Endotoxin | < 1 EU/mL |
| Microbial safety | Sterility | Negative |
| Microbial safety | Mycoplasma | Negative |
| Microbial safety | Replication competent lentivirus (RCL) | Not detected |
| Microbial safety | HIV infectivity | Not detected (CPE)a; ≤ LLOQb (Vif RT-qPCR) |
| Microbial safety | Transgene mobilization | Not detected |
aCPE, cytopathic effect.
bLLOQ, lower limit of quantitation.